You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 70710-1668


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70710-1668

Drug NameNDCPrice/Unit ($)UnitDate
PROCHLORPERAZINE 10 MG TAB 70710-1668-01 0.23067 EACH 2025-03-19
PROCHLORPERAZINE 10 MG TAB 70710-1668-01 0.21092 EACH 2025-02-19
PROCHLORPERAZINE 10 MG TAB 70710-1668-01 0.19046 EACH 2025-01-22
PROCHLORPERAZINE 10 MG TAB 70710-1668-01 0.18855 EACH 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 70710-1668

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
PROCHLORPERAZINE MALEATE 10MG TAB Golden State Medical Supply, Inc. 70710-1668-01 100 32.49 0.32490 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for the Drug NDC: 70710-1846

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by a myriad of factors including regulatory changes, technological advancements, and market demand. This article focuses on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 70710-1846, which is associated with Scopolamine 1 MG/3 Day Patch.

Drug Overview

Scopolamine 1 MG/3 Day Patch, identified by NDC 70710-1846, is a transdermal patch used primarily for the prevention of nausea and vomiting associated with motion sickness and postoperative nausea and vomiting. This medication is available in various package sizes, each containing a specific number of patches[1].

Historical Pricing

Historical data shows that the pricing for Scopolamine 1 MG/3 Day Patch has been relatively stable over recent months. As of December 18, 2024, the price per unit for this drug was $5.34526 across different package sizes. However, there have been slight fluctuations, with prices dropping to $4.68559 per unit in November 2024 before returning to the higher rate[1].

Current Market Dynamics

The current market for Scopolamine 1 MG/3 Day Patch is characterized by a stable pricing environment, which is typical for drugs that are not subject to intense market competition or recent regulatory changes. The presence of a single or few manufacturers can sometimes lead to less volatility in pricing, but it also means that any changes in the supply chain or manufacturing costs can have a more pronounced effect on prices.

Future Projections

Pricing Stability

Given the current trends, it is likely that the prices for Scopolamine 1 MG/3 Day Patch will remain relatively stable in the near future. Generic drugs, while subject to some price fluctuations, generally experience less dramatic price changes compared to brand-name drugs. However, any significant changes in raw material costs, manufacturing efficiencies, or market demand could impact pricing[2].

Regulatory Impact

Regulatory changes can significantly influence drug pricing. For instance, proposals for upper payment limits or other regulatory measures aimed at controlling drug prices could affect the pricing strategy for Scopolamine 1 MG/3 Day Patch. However, as of now, there are no specific regulatory changes anticipated that would directly impact this drug[2].

Market Competition

The market for Scopolamine 1 MG/3 Day Patch is not highly competitive, which can contribute to price stability. However, the entry of new generic manufacturers or changes in market demand could alter the pricing landscape. As seen in other markets, the presence of multiple generic manufacturers typically keeps prices in check[3].

Global Pricing Context

U.S. vs. International Prices

The U.S. pharmaceutical market is known for having higher drug prices compared to other regions. For example, the average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity highlights the unique pricing dynamics in the U.S. market, which can be influenced by factors such as regulatory frameworks, market demand, and the mix of high-cost drugs[4].

Impact of Technological Advancements

The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. Technologies like genomics, biomarkers, and AI are expected to boost operational efficiencies and drive breakthrough innovations. While these advancements are more likely to impact new drug development and personalized medicine, they can also influence the overall market dynamics and pricing strategies for existing drugs[3].

Role of the FDA's NDC Directory

The FDA's National Drug Code (NDC) Directory plays a crucial role in tracking and managing drug products, ensuring compliance and transparency. The NDC Directory contains information on active and certified finished and unfinished drugs, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged and relabeled drugs. This directory helps in monitoring the market and ensuring that all drug products comply with regulatory standards[5].

Key Takeaways

  • Pricing Stability: The prices for Scopolamine 1 MG/3 Day Patch are expected to remain relatively stable due to the lack of intense market competition and regulatory changes.
  • Regulatory Oversight: Regulatory changes can significantly impact drug pricing, but as of now, no specific changes are anticipated for this drug.
  • Market Dynamics: The market for this drug is characterized by stable pricing, but any changes in supply chain or manufacturing costs could affect prices.
  • Global Context: U.S. drug prices, including those for Scopolamine 1 MG/3 Day Patch, are generally higher than in other regions.
  • Technological Advancements: While primarily affecting new drug development, technological advancements can influence overall market dynamics.

FAQs

Q: What is the current price per unit for Scopolamine 1 MG/3 Day Patch? A: As of December 18, 2024, the price per unit for Scopolamine 1 MG/3 Day Patch is $5.34526[1].

Q: What factors can influence the pricing of Scopolamine 1 MG/3 Day Patch? A: Factors such as changes in raw material costs, manufacturing efficiencies, market demand, and regulatory changes can influence the pricing of this drug[2].

Q: How does the U.S. market compare to international markets in terms of drug prices? A: The U.S. market has significantly higher drug prices compared to other regions, with prices being 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].

Q: What role does the FDA's NDC Directory play in the pharmaceutical market? A: The FDA's NDC Directory ensures compliance and transparency by tracking and managing drug products, including finished and unfinished drugs, and ensuring all products comply with regulatory standards[5].

Q: How might technological advancements impact the pricing and market dynamics of Scopolamine 1 MG/3 Day Patch? A: While technological advancements are more likely to impact new drug development, they can also influence overall market dynamics and pricing strategies for existing drugs by improving operational efficiencies and driving innovations[3].

Sources

  1. DrugPatentWatch, "Latest drug prices and trends for NDC 70710-1846".
  2. DrugPatentWatch, "Market analysis and price projections for the drug NDC: 16714-0167".
  3. Deloitte Insights, "2025 life sciences outlook".
  4. ASPE, "International Market Size and Prices".
  5. FDA, "National Drug Code Directory".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.